About VeraSci
VeraSci is a company based in Durham (United States) founded in 2016 was acquired by WIRB-Copernicus Group in July 2021. VeraSci offers products and services including IRB Review, eCOA/ePRO Platform, and Site Enablement. VeraSci operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
WIRB-Copernicus Group
& 1 more
-
Employee Count
Not available
-
Acquired by
WIRB-Copernicus Group
(Jul 26, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VeraSci
VeraSci offers a comprehensive portfolio of products and services, including IRB Review, eCOA/ePRO Platform, and Site Enablement.
Provides ethical review for clinical trials and studies
Platform for electronic data collection in clinical trials
Assists with study start-up and resource management
Funding Insights of VeraSci
Investors in VeraSci
VeraSci has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include WIRB-Copernicus Group and SBIR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Federal innovation and scientific achievement services are provided.
|
Locked | Locked | Locked | |
|
Regulatory and ethical review services for clinical research are provided.
|
Locked | Locked | Locked |
Investor details for VeraSci
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VeraSci
Investment portfolio details for VeraSci
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VeraSci
Detailed financials for VeraSci
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verasci Comparisons
Peer comparison for VeraSci
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VeraSci
VeraSci operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Innovative therapies for treating and curing viral diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service clinical research services are provided to life science industries.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of VeraSci
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verasci
Complete news archive for VeraSci
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VeraSci
VeraSci was founded in 2016.
VeraSci is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
VeraSci, backed by 1400000.0 from SBIR, focuses on providing healthcare solutions, biopharma outsourcing, cro, clinical development, functional services, and diversified. Provider of data management and site selection services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
VeraSci's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.
VeraSci offers IRB Review, eCOA/ePRO Platform, and Site Enablement.
VeraSci has 2 investors. Key investors include WIRB-Copernicus Group, and SBIR.